Complement C5-blocking Agent in Refractory Dermatomyositis
Author:
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference11 articles.
1. Recent clinical trials in idiopathic inflammatory myopathies;Leclair;Curr Opin Rheumatol,2017
2. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
3. Idiopathic inflammatory myopathies: a review of the classification and impact of pathogenesis;Mandel;Int J Mol Sci,2017
4. Polymyositis and Dermatomyositis
5. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors);Winthrop;Clin Microbiol Infect,2018
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons;Expert Review of Clinical Immunology;2023-10-17
2. Past, Present, and Future in Dermatomyositis Therapeutics;Current Treatment Options in Rheumatology;2022-07-26
3. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review;International Journal of Molecular Sciences;2022-04-13
4. Anti-complement Agents for Autoimmune Neurological Disease;Neurotherapeutics;2022-04
5. Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options;Neurotherapeutics;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3